Skip to main content

Clinical Trials in Korea

Registration requirement​

Clinical trials should be registered in an MFDS-recognised registry such as ClinicalTrials.gov or CRIS, typically before the first participant is enrolled, though registration can occur within 30 days of enrollment start:

Investigational device labelling​

Must be labelled: "μž„μƒμ‹œν—˜μš© 의료기기 (Investigational Device)"

Trial types (device-specific)​

  • Feasibility study β€” early-phase safety and signal-finding
  • Pivotal trial β€” primary evidence base for ν’ˆλͺ©ν—ˆκ°€

Post-trial obligations​

  • Submit trial completion report to MFDS
  • Report outstanding serious adverse events
  • Retain data/records for the minimum period specified by MFDS regulations